![Alexis Peyroles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexis Peyroles
Net worth: 5 M $ as of 2024-06-29
Profile
Alexis Peyroles is the founder and currently holds the position of Chairman & Chief Financial Officer at Inside Therapeutics SAS, a company founded in 2022.
He is also currently the Chief Executive Officer at Ose Immunotherapeutics, Inc. and Chairman at Aperana Consulting SAS.
Previously, he held the position of Chief Executive Officer & Director at OSE Immunotherapeutics SA from 2018 to 2022.
He has also worked as the Chief Executive Officer at Guerbet Imagem do Brasil Ltda., Manager-Financial Control at Guerbet SA, Head-Financial Control-Baltic States at Sanofi-Aventis Japan, Head-Eastern Europe Business Development at Sanofi-Aventis France SA, and CFO & Head-Business Development at Orphan Synergy Europe-Pharma SA. Mr. Peyroles completed his undergraduate degree at École des Hautes Études Commerciales du Nord and holds an MBA from Imperial College Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-12-30 | 929,862 ( 4.26% ) | 5 M $ | 2024-06-29 |
Alexis Peyroles active positions
Companies | Position | Start |
---|---|---|
Aperana Consulting SAS | Chairman | - |
Ose Immunotherapeutics, Inc. | Chief Executive Officer | - |
Former positions of Alexis Peyroles
Companies | Position | End |
---|---|---|
OSE IMMUNOTHERAPEUTICS | Chief Executive Officer | 2022-01-15 |
Guerbet Imagem do Brasil Ltda. | Chief Executive Officer | - |
Sanofi-Aventis Japan | Comptroller/Controller/Auditor | - |
GUERBET | Comptroller/Controller/Auditor | - |
Sanofi-Aventis France SA
![]() Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | - |
Training of Alexis Peyroles
École des Hautes Études Commerciales du Nord | Undergraduate Degree |
Imperial College Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GUERBET | Health Technology |
OSE IMMUNOTHERAPEUTICS | Health Technology |
Private companies | 6 |
---|---|
Orphan Synergy Europe-Pharma SA
![]() Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
Sanofi-Aventis France SA
![]() Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Aperana Consulting SAS | |
Ose Immunotherapeutics, Inc. | |
Sanofi-Aventis Japan | |
Guerbet Imagem do Brasil Ltda. |
- Stock Market
- Insiders
- Alexis Peyroles